Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic (Tumor Necrosis Factor)TNF-receptor Associated Periodic Syndrome (TRAPS)
This study is ongoing, but not recruiting participants.
Study NCT01242813
Information provided by Novartis
First Received on November 16, 2010.
Last Updated on January 15, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
